Product Information
CEFDINIR 125 MG/5 ML SUSP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0983 per ML under NDC 00093413673. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
125 mg/5mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093413673
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIR MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA065332On Market Since
5/8/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 125 MG/5 ML SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 77.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0983 per ML |
|---|---|
| All-time high | $0.4554 (Jan 15, 2014) |
| All-time low | $0.0920 (Jul 17, 2024) |
| 52-week high | $0.1110 |
| 52-week low | $0.0983 |
| Median price | $0.1287 |
| Average price | $0.1947 |
| Largest weekly change | +50.2% (Oct 21, 2020) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 125 MG/5 ML SUSP, manufactured by Teva Pharmaceuticals USA Inc., is $0.0983 per ML (NDC 00093413673), effective Jun 24, 2026.
How has the price of CEFDINIR 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFDINIR 125 MG/5 ML SUSP has declined 77.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFDINIR 125 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for CEFDINIR 125 MG/5 ML SUSP has ranged from a low of $0.0920 (Jul 17, 2024) to a high of $0.4554 (Jan 15, 2014), with a median of $0.1287 per ML.
Are there cheaper alternatives to CEFDINIR 125 MG/5 ML SUSP?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CEFDINIR 125 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures CEFDINIR 125 MG/5 ML SUSP?
CEFDINIR 125 MG/5 ML SUSP (NDC 00093413673) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification